Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2015

01-08-2015 | Hepatobiliary Tumors

Totally Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy

A New Minimally Invasive Two-Stage Hepatectomy

Authors: Umberto Cillo, MD, FEBS, Enrico Gringeri, MD, PhD, Paolo Feltracco, MD, Domenico Bassi, MD, Francesco E. D’Amico, MD, Marina Polacco, MD, Riccardo Boetto, MD

Published in: Annals of Surgical Oncology | Issue 8/2015

Login to get access

Abstract

Background

Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS) is a new technique with a first laparoscopic step available in cases of unresectable right liver masses and inadequate future liver remnant (FLR).

Methods

In Step 1, laparoscopic right portal vein occlusion is performed with microwave ablation on the future transection plane and in the FLR. Step 2 consists of a totally laparoscopic right trisectionectomy.

Results

Duration of the Step 1 operation was 170 min, without the need for blood transfusions and intensive care unit admission. The postoperative liver volumetric computed tomography scan was performed on postoperative day 9 and revealed a satisfactory left hepatic hypertrophy (FLR 666 cm3; FLR to body weight ratio 0.96; FLR increase 90.4 %; daily FLR hypertrophy 35 cm3/day). Duration of the Step 2 operation was 630 min (liver transection time 240 min). Blood loss was 700 cc, with no need for transfusion. The specimen was extracted through a 10-cm Pfannenstiel incision, and pathology revealed a tumor-free resection margin (R0). The patient was discharged on postoperative day 7 without complications (total hospital stay for Step 1 + Step 2: 10 days).

Conclusions

Totally LAPS is a technically feasible and safe procedure. It could provide benefit in selected patients with primarily non-resectable liver cancer, making extreme liver surgery easy and safe in well-selected patients.
Appendix
Available only for authorised users
Literature
1.
Shadde E, Ardiles V, Slankamenac K, et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg. 2014;38(6);1510–1519.CrossRef
2.
Gringeri E, Boetto R, Bassi D, et al. Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS): a minimally invasive first-step approach. Ann Surg. 2015;261(2):e42–e43.PubMedCrossRef
3.
4.
Machado MA, Makdissi FF, Surjan RC. Totally laparoscopic ALPPS is feasible and may be worthwhile. Ann Surg. 2012;256(3):e13.PubMedCrossRef
Metadata
Title
Totally Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy
A New Minimally Invasive Two-Stage Hepatectomy
Authors
Umberto Cillo, MD, FEBS
Enrico Gringeri, MD, PhD
Paolo Feltracco, MD
Domenico Bassi, MD
Francesco E. D’Amico, MD
Marina Polacco, MD
Riccardo Boetto, MD
Publication date
01-08-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 8/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4353-7

Other articles of this Issue 8/2015

Annals of Surgical Oncology 8/2015 Go to the issue

Endocrine Tumors

Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group

Gastrointestinal Oncology

Comparison of Reduced Port Totally Laparoscopic Distal Gastrectomy (Duet TLDG) and Conventional Laparoscopic-Assisted Distal Gastrectomy

Thoracic Oncology

Pattern of Postoperative Mortality After Esophageal Cancer Resection According to Center Volume: Results from a Large European Multicenter Study

Breast Oncology

The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy

Breast Oncology

Deviation from the Standard of Care for Early Breast Cancer in the Elderly: What are the Consequences?

Colorectal Cancer

Early and Late Outcomes of Surgery for Locally Recurrent Rectal Cancer: A Prospective 10-Year Study in the Total Mesorectal Excision Era